每經(jīng)AI快訊,3月9日,據(jù)華潤醫(yī)藥商業(yè)官微消息,華潤醫(yī)藥商業(yè)與羅氏制藥于3月7日正式簽署合作協(xié)議。雙方將共同推動乳腺癌治療領域的藥物恩美曲妥珠單抗在中國大陸的商業(yè)化運營。
特別聲明:以上內(nèi)容(如有圖片或視頻亦包括在內(nèi))為自媒體平臺“網(wǎng)易號”用戶上傳并發(fā)布,本平臺僅提供信息存儲服務。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.